Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 13,000 shares at $17.46 ($227K) on 2019-12-06, disclosed to the SEC on 2019-12-10.
Open-market sale of $227k KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.45 | 5,000 | $87K | 38.4% |
| 2 | $17.46 | 3,000 | $52K | 23.1% |
| 3 | $17.46 | 5,000 | $87K | 38.5% |
| Total | $17.46 avg | 13,000 | $227K | 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |